文献速递物质与行为成瘾

捕捉丁丙诺啡治疗反应的全貌

Capturing the Full Range of Buprenorphine Treatment Response.
PubMed 文献 · JAMA Psychiatry · 2025-01-01

该研究为4项随机临床试验的二次分析,纳入869例阿片使用障碍(OUD)患者,评估丁丙诺啡联合医疗咨询(BUP+MC)治疗12周内非法阿片使用天数变化;仅43%患者符合基于戒断的成功标准,但总样本从基线每周6.21天降至第12周0.54天,即使被判定为不成功者亦从6.29天降至1.51天。

要点

  • 仅377例(43%)符合基于戒断的成功标准,但总样本非法阿片使用从基线每周6.21天降至第12周0.54天。
  • 被判定为不成功者仍从每周6.29天降至1.51天,显示部分治疗反应。
  • 作者认为需未来研究刻画这些减少与功能及长期结局的关联。

核心结论

  • 约半数接受BUP+MC的患者达到近乎完全戒断,但更多患者经历非法阿片使用大幅减少但未达戒断的部分治疗反应。
  • 未来研究需刻画这些减少如何与功能及长期结局相关联。
  • 鉴于该干预稳健的平均反应,将BUP+MC作为标准丁丙诺啡处方实践的一部分进行传播是必要的下一步。

研究设计与样本

  • 本研究为对4项 harmonized 随机临床试验的二次数据分析,这些试验评估BUP+MC治疗OUD,来自多个站点,纳入869例OUD患者。
  • 数据分析于2024年4月23日进行;至第12周,原样本中643例(74%)仍留存。
  • 所有研究均纳入随机分配至BUP+MC或BUP联合增强MC(如辅以认知行为治疗)的患者。

主要发现

  • 共纳入869例OUD成人,年龄18至69岁(均值34.2[SD 10.45]岁);287例女性(33%),52例黑人(6%),70例西班牙裔(8%),713例白人(82%),34例其他种族(4%)。
  • 仅377例(43%)按基于戒断的成功规则会被标记为成功。
  • 总样本报告非法阿片使用从基线均值近乎每日(每周6.21[SD 1.50]天)降至第12周均值每周少于1天(0.54[SD 1.28]天)。
  • 即使被标记为不成功者,非法阿片使用亦从每周6.29[SD 1.42]天大幅降至每周1.51[SD 1.76]天。

关键数值与推荐

  • 成功规则:基于戒断的治疗结局规则,仅377例(43%)符合。
  • 主要结局:治疗12周内每周自我报告的非法阿片使用天数,戒断由尿药筛查确认。

临床怎么用

  • 作者认为,鉴于BUP+MC稳健的平均反应,将其作为标准丁丙诺啡处方实践的一部分进行传播是必要的下一步。

局限性

  • 未来研究需刻画这些减少如何与功能及长期结局相关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Reliance on abstinence-based treatment success rules may fail to capture the full continuum of treatment response to buprenorphine plus medical counseling (BUP+MC) for opioid use disorder (OUD). OBJECTIVE: To describe patterns of reduction in illicit opioid use of patients both labeled as a success and nonsuccess based on an abstinent-based treatment outcome rule. DESIGN, SETTING, AND PARTICIPANTS: This study is a secondary data analysis of 4 harmonized randomized clinical trials on BUP+MC for OUD from multiple sites that included 869 patients with OUD. These data were analyzed on April 23, 2024. By week 12, 643 participants of the sample original remained (74%). INTERVENTION: All studies included patients randomized to BUP+MC or BUP plus enhanced MC (eg, delivered with adjunctive cognitive behavioral therapy). MAIN OUTCOMES AND MEASURES: Weekly self-reported days of illicit opioid use through 12 weeks of treatment. Abstinence was confirmed by urine drug screen. RESULTS: This study included 869 adults with OUD aged 18 to 69 (mean, 34.2 [SD, 10.45]) years; 287 patients were female (33%), 52 identified as Black (6%), 70 identified Hispanic (8%), 713 identified as White (82%), and 34 identified as other racial groups (4%). Only 377 patients (43%) would have been labeled a success using an abstinence-based success rule. However, the total sample reported a decrease from a mean baseline rate of illicit opioid use nearly every day (6.21 [SD, 1.50] days per week) to a mean of less than 1 day per week at week 12 (0.54 [SD, 1.28]). Importantly, even those who were labeled as nonsuccessful reported a substantial reduction in opioid use from a mean of 6.29 (SD, 1.42) days per week to 1.51 (SD, 1.76) days per week. CONCLUSION AND RELEVANCE: In this study, about half of patients receiving BUP+MC achieved near complete abstinence; however, many more experienced a partial treatment response characterized by a substantial reduction in illicit opioid use that falls short of abstinence. Future studies are needed to characterize how these reductions are associated with functional and long-term outcomes. Dissemination of BUP+MC as part of standard buprenorphine prescribing practices is an essential next step given the robust average response of this intervention.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Bailey AJ, Votaw VR, Weiss RD, et al. Capturing the Full Range of Buprenorphine Treatment Response. JAMA Psychiatry. 2025. PMID: 39630467. doi:10.1001/jamapsychiatry.2024.3836

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。